653O Glecirasib (KRAS G12C inhibitor) in combination with JAB-3312 (SHP2 inhibitor) in patients with KRAS p.G12C mutated solid tumors
Juan Wang, Jun Zhao, Jia Zhong, Xingang Li, Jian Fang, Yan Yu, X. Li, Xinyi Fang, J. Chang, Zhonghua Liu, Yajie Zhao, Qibin Song, Chunmei Bai, A. Wang-Gillam, Yi Ding, Zihe Rao, Changlong Bi
Topics & Concepts
KRASMedicineCancer researchPharmacologyInternal medicineCancerColorectal cancerColorectal Cancer Treatments and StudiesMelanoma and MAPK PathwaysPI3K/AKT/mTOR signaling in cancer